As of April 16, 2025, Terns Pharmaceuticals (TERN) has a market cap of $0.21 billion USD. According to our data, Terns Pharmaceuticals is ranked No.6925 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.21 B |
-55.48%
|
Dec 31, 2024 | $0.47 B |
-14.64%
|
Dec 29, 2023 | $0.55 B |
-36.25%
|
Dec 30, 2022 | $0.86 B |
43.99%
|
Dec 31, 2021 | $0.60 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Madrigal Pharmaceuticals
MDGL
|
$7.09 B |
-0.000 M
|
![]() USA
|
![]() Viking Therapeutics
VKTX
|
$2.59 B |
-0.000 M
|
![]() USA
|
![]() Galmed Pharmaceuticals
GLMD
|
$3.18 M |
0.000 M
|
![]() Israel
|
![]() Akero Therapeutics
AKRO
|
$3.03 B |
0.000 M
|
![]() USA
|
![]() 89bio
ETNB
|
$0.88 B |
-0.000 M
|
![]() USA
|
![]() Genfit
GNFT
|
$0.18 B |
0.000 M
|
![]() France
|
![]() Enanta Pharmaceuticals
ENTA
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
Market Cap | = | TERN Stock Price | * | TERN Shares Outstanding |
= | $2.40 | * | 87.30 M | |
= | $0.21 B |